249 related articles for article (PubMed ID: 31205555)
1. Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas.
Kim S; Choi MC; Jeong JY; Hwang S; Jung SG; Joo WD; Park H; Song SH; Lee C; Kim TH; An HJ
J Cancer; 2019; 10(9):1958-1967. PubMed ID: 31205555
[No Abstract] [Full Text] [Related]
2. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
Kobayashi M; Sawada K; Nakamura K; Yoshimura A; Miyamoto M; Shimizu A; Ishida K; Nakatsuka E; Kodama M; Hashimoto K; Mabuchi S; Kimura T
J Ovarian Res; 2018 Sep; 11(1):81. PubMed ID: 30219071
[TBL] [Abstract][Full Text] [Related]
4. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
5. Bile-derived exosome noncoding RNAs as potential diagnostic and prognostic biomarkers for cholangiocarcinoma.
Pan Y; Shao S; Sun H; Zhu H; Fang H
Front Oncol; 2022; 12():985089. PubMed ID: 36091129
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
7. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-200 family as serum biomarkers for early detection and prognostic prediction of cholangiocarcinoma.
Shen L; Chen G; Xia Q; Shao S; Fang H
Int J Clin Exp Pathol; 2019; 12(10):3870-3876. PubMed ID: 31933776
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.
Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM
BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653
[TBL] [Abstract][Full Text] [Related]
11. Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma.
Reese M; Flammang I; Yang Z; Dhayat SA
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31941049
[TBL] [Abstract][Full Text] [Related]
12. Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer.
Jeon H; Seo SM; Kim TW; Ryu J; Kong H; Jang SH; Jang YS; Kim KS; Kim JH; Ryu S; Jeon S
Curr Issues Mol Biol; 2022 Jan; 44(1):288-300. PubMed ID: 35723400
[TBL] [Abstract][Full Text] [Related]
13. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009
[TBL] [Abstract][Full Text] [Related]
14. Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis.
Yu Y; Bai F; Qin N; Liu W; Sun Q; Zhou Y; Yang J
Nephron; 2018; 139(3):269-282. PubMed ID: 29539618
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.
Gao YC; Wu J
Tumour Biol; 2015 Jun; 36(6):4843-50. PubMed ID: 25636451
[TBL] [Abstract][Full Text] [Related]
16. Exosomal microRNAs as tumor markers in epithelial ovarian cancer.
Pan C; Stevic I; Müller V; Ni Q; Oliveira-Ferrer L; Pantel K; Schwarzenbach H
Mol Oncol; 2018 Nov; 12(11):1935-1948. PubMed ID: 30107086
[TBL] [Abstract][Full Text] [Related]
17. Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer.
Záveský L; Jandáková E; Weinberger V; Minář L; Hanzíková V; Dušková D; Drábková LZ; Svobodová I; Hořínek A
Reprod Sci; 2019 Apr; 26(4):510-522. PubMed ID: 29779470
[TBL] [Abstract][Full Text] [Related]
18. Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients.
Li Z; Ma YY; Wang J; Zeng XF; Li R; Kang W; Hao XK
Onco Targets Ther; 2016; 9():139-48. PubMed ID: 26770063
[TBL] [Abstract][Full Text] [Related]
19. Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis.
Chen Z; Liang Q; Zeng H; Zhao Q; Guo Z; Zhong R; Xie M; Cai X; Su J; He Z; Zheng L; Zhao K
J Cancer; 2020; 11(21):6445-6453. PubMed ID: 33033528
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
Taylor DD; Gercel-Taylor C
Gynecol Oncol; 2008 Jul; 110(1):13-21. PubMed ID: 18589210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]